Biosecurity and Hygiene Treatments and prevention Managing disease MAF Biosecurity Renews FMD Antigen Contract NEW ZEALAND - MAF Biosecurity New Zealand (MAFBNZ) has extended its contract with a French manufacturer of Foot and Mouth (FMD) disease antigen and vaccine. 12 July 2010 2 minute read Oceania Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive More News View all Olymel announces closure of Quebec processing plant Company News 23 April 2024 2 minute read The Paris Olympics menu: more French, more local, less meat Market Trends 23 April 2024 2 minute read 60% of the meals offered spectators will be vegetarian ADM CFO to resign as company faces US government investigation Market Trends Feed markets Company News 23 April 2024 2 minute read ADM forced to revise six years of financial data Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive